[01PacRimLPolyJ299] How the East Was Won: A Critique Of U.S. Tactics In Negotiating Patent Protection for Pharmaceuticals In Thailand

digital.law/Manakin Repository

[01PacRimLPolyJ299] How the East Was Won: A Critique Of U.S. Tactics In Negotiating Patent Protection for Pharmaceuticals In Thailand

Show simple item record

dc.contributor.author Begg, Michael
dc.date 1992-01
dc.date.accessioned 2011-02-24T17:55:33Z
dc.date.available 2011-02-24T17:55:33Z
dc.date.issued 1992-06
dc.identifier.citation 1 Pac. Rim L. & Pol'y J. 299 (1992) en_US
dc.identifier.issn 1066-8632
dc.identifier.uri http://hdl.handle.net/1773.1/1001
dc.description.abstract Michael Begg, B.A., 1991 University of Victoria; LL.B. candidate 1993, University of Victoria, Victoria, British Columbia, Canada. Abstract: In February 1992, Thailand amended its patent law to provide patent protection for drugs. The amendment resulted from pressure by the United States pharmaceutical industry and the United States Trade Representative; it was not a Thai internal policy decision. Bleak prospects in the U.S. drug market due to a climate of increasing restraints on drug prices have led the Pharmaceutical Manufacturers Association to push for patent protection for their products abroad. Consequently, the United States Trade Representative pressured Thailand to amend its Patent Act to include pharmaceuticals, threatening to use Section 337 of the Trade and Tariff Act of 1930 and Section 301 of the Trade and Tariff Act of 1974 against it, and threatening the revocation of GSP (Generalized System of Preferences) benefits. This Comment examines the tactics employed by the United States between 1988 and 1992 in its negotiations with Thailand for patent protection for pharmaceuticals and the assumptions underlying those tactics. The evidence indicates that Thailand may not yet be economically, structurally and socially ready for drug patent protection and the step toward industrialization it represents. The Comment further concludes that the United States' tactics do not accord with a rational concept of trade negotiations, and are likely to harm its interests in the long term by injuring its relationship with Thailand. Moreover, the United States' moral claims with regard to the necessity of patent protections are unjustified. The Comment suggests that a truly multilateral resolution of international drug patent problems is appropriate and proposes that the World Intellectual Property Organization be reconsidered in that regard in future patent protection negotiations with Thailand and other developing countries. en_US
dc.language.iso en_US en_US
dc.publisher Seattle: Pacific Rim Law & Policy Journal, University of Washington School of Law en_US
dc.subject Comment en_US
dc.title [01PacRimLPolyJ299] How the East Was Won: A Critique Of U.S. Tactics In Negotiating Patent Protection for Pharmaceuticals In Thailand en_US
dc.type Article en_US
dc.rights.holder Copyright 1992 by Pacific Rim Law & Policy Association en_US

Files in this item

Files Size Format View
1PacRimLPolyJ299.pdf 3.323Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Search digital.law


Advanced Search

Browse

My Account